Hypotheses and Research
Discover the groundbreaking research UC Well supports, including studies on hydrogen peroxide's role in UC and other innovative hypotheses.
.avif)
What is our foundation's
goals?
UC Well is dedicated to transforming the understanding and treatment of Ulcerative Colitis by challenging traditional assumptions and exploring innovative research avenues. The foundation emphasizes investigating potential root causes of UC, such as the role of hydrogen peroxide, aiming to move beyond symptom management and towards a definitive cure.
Help us find a cure to ulcerative colitis
By donating you help our foundation reach its goals to find a cure to ulcerative colitis
Our roadmap
🗓️ Year 1: 2025–2026 – Establishing Research Foundations
Objective: Initiate foundational studies to explore alternative hypotheses regarding UC's etiology.
Actions:
• Fund preliminary research projects focusing on proof of concept causes of UC.
• Collaborate with independent researchers and institutions to design studies examining the role of hydrogen peroxide in UC development.
• Develop and disseminate educational materials to raise awareness about alternative UC hypotheses.
Actions:
• Fund preliminary research projects focusing on proof of concept causes of UC.
• Collaborate with independent researchers and institutions to design studies examining the role of hydrogen peroxide in UC development.
• Develop and disseminate educational materials to raise awareness about alternative UC hypotheses.
🗓️ Year 2: 2026–2027 – Expanding Research and Community Engagement
Objective: Broaden research initiatives and strengthen community support structures.
Actions:
• Support longitudinal studies to assess the efficacy of treatments targeting newly identified UC mechanisms.
• Organize workshops and seminars to share research findings with the medical community and the public.
• Establish support groups and peer networks for individuals affected by UC.
Actions:
• Support longitudinal studies to assess the efficacy of treatments targeting newly identified UC mechanisms.
• Organize workshops and seminars to share research findings with the medical community and the public.
• Establish support groups and peer networks for individuals affected by UC.
🗓️ Year 3: 2027–2028 – Translating Research into Practice
Objective: Apply research findings to develop practical treatment approaches and influence clinical practices.
Actions:
• Collaborate with healthcare providers to pilot new treatment protocols based on research outcomes.
• Advocate for the inclusion of alternative UC treatment strategies in medical guidelines.
• Publish comprehensive reports detailing research findings and their implications for UC treatment.
Actions:
• Collaborate with healthcare providers to pilot new treatment protocols based on research outcomes.
• Advocate for the inclusion of alternative UC treatment strategies in medical guidelines.
• Publish comprehensive reports detailing research findings and their implications for UC treatment.
What we Believe In
Our Mission
Our nonprofit organization is dedicated to advancing the understanding of ulcerative colitis by investigating its underlying causes and pathophysiology through evidence-based research.
We aim to foster a collaborative environment that prioritizes scientific integrity and transparency, free from external financial influences.
We aim to foster a collaborative environment that prioritizes scientific integrity and transparency, free from external financial influences.
Our Vision
We envision a world where individuals affected by ulcerative colitis receive accurate diagnoses and effective treatments based on a deep understanding of the disease's origins.
Our commitment to education, awareness, and support will empower patients and their families, ensuring they have the resources and knowledge necessary to navigate their journey with ulcerative colitis.
Our commitment to education, awareness, and support will empower patients and their families, ensuring they have the resources and knowledge necessary to navigate their journey with ulcerative colitis.
A word from our President
My name is Richard Gordon MD, and I am a practicing Cardiologist in Prescott, Arizona and the President of UC Well. During my teenage years, I was diagnosed with ulcerative colitis, a condition that significantly impacted my health and quality of life for over three decades.
As my disease progressed, it became refractory, leading to persistent rectal bleeding and leaving me on the verge of requiring a total colectomy. Fortunately, my gastroenterologist was open to exploring an innovative therapy developed by Dr. Jay Pravda. Remarkably, within just a few weeks of beginning treatment, I experienced a full recovery, with normal bowel function restored.
A colonoscopy and biopsy conducted twelve years later, in 2012, confirmed the complete absence of disease, and I continue to remain in excellent health to this day. Based on current medical understanding, my ulcerative colitis has been effectively cured. After observing others whose ulcerative colitis has completely resolved, I am convinced that Dr. Pravda’s therapy may effectively target the underlying cause and holds the potential to serve as a cure for millions who are suffering with this disease.
Inspired by these promising outcomes, our group established UC Well with a singular mission: to conduct rigorous clinical studies that will objectively ensure its availability to all individuals affected by ulcerative colitis. Our initial objective is to secure $2 million in funding to conduct a proof-of-principle clinical study. This study will provide critical insights into how we can advance toward a clinical trial, ultimately making this treatment accessible to all individuals affected by ulcerative colitis. With your support, I firmly believe there is a real opportunity to achieve a true cure for this disease.
Richard Gordon MD, CEO UC Well
As my disease progressed, it became refractory, leading to persistent rectal bleeding and leaving me on the verge of requiring a total colectomy. Fortunately, my gastroenterologist was open to exploring an innovative therapy developed by Dr. Jay Pravda. Remarkably, within just a few weeks of beginning treatment, I experienced a full recovery, with normal bowel function restored.
A colonoscopy and biopsy conducted twelve years later, in 2012, confirmed the complete absence of disease, and I continue to remain in excellent health to this day. Based on current medical understanding, my ulcerative colitis has been effectively cured. After observing others whose ulcerative colitis has completely resolved, I am convinced that Dr. Pravda’s therapy may effectively target the underlying cause and holds the potential to serve as a cure for millions who are suffering with this disease.
Inspired by these promising outcomes, our group established UC Well with a singular mission: to conduct rigorous clinical studies that will objectively ensure its availability to all individuals affected by ulcerative colitis. Our initial objective is to secure $2 million in funding to conduct a proof-of-principle clinical study. This study will provide critical insights into how we can advance toward a clinical trial, ultimately making this treatment accessible to all individuals affected by ulcerative colitis. With your support, I firmly believe there is a real opportunity to achieve a true cure for this disease.
Richard Gordon MD, CEO UC Well
Contact UC Well
Do you have a question about the foundation or would you like to learn more about our research program? Please send us a message, we will get back at you as soon as possible.
